Skip to main content
Clinical Trials/NCT02062008
NCT02062008
Terminated
N/A

Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications

University of California, San Francisco1 site in 1 country2 target enrollmentDecember 2016
ConditionsCardiac Disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiac Disease
Sponsor
University of California, San Francisco
Enrollment
2
Locations
1
Primary Endpoint
Number of Quality PET and PET/MR Images With Regional Myocardial Uptake of 18F-Fluorodeoxyglucose (FDG) in Participants Without Overt Diagnosis of Ischemic Coronary Artery Disease.
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to understand how simultaneous PET/MR acquisition can provide novel qualitative and quantitative biomarkers to guide clinical intervention and predict prognosis of patients with cardiovascular disease.

Detailed Description

* To compare regional myocardial uptake of FDG on images obtained on a standard PET camera with the new PET/MR camera, in patients with coronary artery disease. * To compare viability maps obtained with cardiac MR images and FDG-PET for delineation of myocardial infarct core and border zone, in patients with coronary artery disease. * To correlate MRI myocardial strain with relative myocardial FDG uptake in patients with a previous myocardial infarction. * To interrogate if simultaneous acquisition of cardiac PET and viability cardiac MR differ from acquisitions obtained independently, with special focus on attenuation correction methods * To combined MRI scar map with FDG-PET uptake in patients with cardiac sarcoidosis and myocarditis. * To correlate morphologic characteristics of atherosclerotic disease in the thoracic and abdominal aorta with FDG uptake and ferumoxytol enhancement, as a marker of inflammation. * To evaluate cardiac strain and myocardial scar burden in obese patients with and without diabetes.

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
February 10, 2018
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects with ischemic and non-ischemic cardiac disease referred for cardiac PET for viability imaging.

Exclusion Criteria

  • Contraindications for MRI, including cardiac pacemaker, claustrophobia, retained metallic foreign body, cochlear implant, Aneurysm clip in the brain, pregnancy and eGFR less than 45%.

Outcomes

Primary Outcomes

Number of Quality PET and PET/MR Images With Regional Myocardial Uptake of 18F-Fluorodeoxyglucose (FDG) in Participants Without Overt Diagnosis of Ischemic Coronary Artery Disease.

Time Frame: 2 hours

Visual analysis of collected image pairs. Evaluated by experienced imaging providers as yes or no.

Study Sites (1)

Loading locations...

Similar Trials